Skip to content

Rotator Cuff Tendinopathy Exercise Trial

Progressive Heavy Strength Training Compared to General Low-load Exercises in Patients With Rotator Cuff Tendinopathy: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01984203
Acronym
RoCTEx
Enrollment
100
Registered
2013-11-14
Start date
2013-11-30
Completion date
2015-10-31
Last updated
2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Tendinitis

Keywords

Shoulder, Impingement, Rotator Cuff Syndrome, Subacromial Impingement Syndrome, Exercise, Physiotherapy

Brief summary

This study aims at determine if Progressive Heavy Load Exercises (PHLE) as treatment for patients diagnosed with Rotator Cuff Tendinopathy is superior to Standard Low-Load Exercises (LLE).

Detailed description

The trial will be performed as a multicenter randomised controlled trail, including 110 patients diagnosed with Rotator Cuff Tendinopathy from four orthopaedic shoulder clinics in secondary sector in Denmark. The PHLE intervention will consist of progressive strengthening exercises performed with heavy load dumbbells, targeting the rotator cuff in a 12 weeks home-exercise program with six control visits at a physiotherapy department at the hospitals. The LLE exercise program consists of the same exercises as the PHLE, but performed with low load dumbbells. Disability of the Arm, Shoulder and Hand (DASH) questionnaire is used as the primary outcome and is measured 12 weeks post baseline. 12 months post baseline a secondary follow-up will be performed primarily measuring the number of patients referred to an operation. Patients will be randomised to either PHLE or LLE regime by blocks according to whether they have been referred to corticosteroid injection by their orthopaedic shoulder specialist. \*April 2015: (We originally expected to be able to include 260 patients in order to analyze our data according to the sub-groups of exercise group +/- Corticosteroid injection, but inclusion rate has been much lower then expected, and due to time restraints we only expect to include 110 patients) Primary investigator and patients will be blinded towards group assignment.

Interventions

All rotator cuff and scapular exercises are performed with 3 sets of 20 repetitions 3 times per week for 12 weeks. The load is set at around 60% of 1 RM (20 reps). The glenohumeral/postural corrective exercises are performed with 3 sets of 5 repetitions (The position is held for 15 seconds per repetition).

OTHERProgressive Heavy Strength Exercises

All scapular exercises are performed with 3 sets of 20 repetitions 3 times per week for 12 weeks. The load is set at around 60% of 1 RM (20 reps). The rotator cuff exercises are performed with 4 sets of gradually progressive loading and decreasing the repetitions performed in each set. Week 1: 15reps (70% 1RM) Week 2-3: 12 reps (75% 1RM) Week 4-5: 10 reps (80% 1RM) Week 6-8: 8 reps (85% 1RM) Week 9-12: 6 reps (90% 1RM) The glenohumeral/postural corrective exercises are performed with 3 sets of 5 repetitions (The position is held for 15 seconds per repetition).

Sponsors

Region of Southern Denmark
CollaboratorOTHER
Sygehus Lillebaelt
CollaboratorOTHER
Aalborg University Hospital
CollaboratorOTHER
Odense University Hospital
CollaboratorOTHER
University of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients between 18 and 65 years of age * history of shoulder complaints lasting at least 3 months prior to enrolment * Pain located in the proximal lateral aspect of the upper arm (C5 dermatome) aggravated by abduction * Positive Full Can test AND/OR Jobes test/Empty Can test AND/OR Resisted External Rotation test * Positive Hawkins-Kennedy test AND/OR Neers test * Ultra-sonographic verification of tendon swelling, hypo echoic areas, fibrillar disruption or neovascularization in the RC.

Exclusion criteria

* Resting pain more than 40 mm on a visual analogue scale (VAS); * Bilateral shoulder pain * Less than 90 degrees of active elevation of the arm; * Full thickness RC rupture verified by ultra-sonography; * Corticosteroid injection within the last 6 weeks; * Radiologic verified fracture, calcification larger then 5 mm (vertical distance) in the RC tendon, glenohumeral arthrosis or malalignment in the shoulder complex; * Prior surgery or dislocation of the affected shoulder; * Clinically suspected labrum lesion, arthritis in the AC-joint, frozen shoulder or symptoms derived from the cervical spine; * Sensory or motor deficit in neck or arm; * Suspected competing diagnoses (e.g., Rheumatoid arthritis, Cancer, Neurological disorders, Fibromyalgia, Schizophrenia, Suicidal threatened, Borderline personality disorder, or Obsessive Compulsive Disorder); * Pregnancy; * Inability to fluently understand written and spoken Danish.

Design outcomes

Primary

MeasureTime frame
Change from baseline in Disability of the Arm, Shoulder and Hand questionnaire at 12 weeksBaseline and 12 weeks

Secondary

MeasureTime frame
Change from baseline in Isometric Strength (MVC)Baseline and 12 weeks
Change from baseline in Range of movementBaseline and 12 weeks
Number of patients referred to or completed arthroscopic shoulder operation12 months
Change in Shoulder injury and Osteoarthritis Outcome Score - (SOOS) at 12 weeksBaseline and 12 weeks
Hospital Anxiety and Depressions score - (HAD)Baseline
Scapula Retraction testBaseline
Change in Shoulder injury and Osteoarthritis Outcome Score - (SOOS) at 52 weeksBaseline and 52 weeks
Change in Euro Qol 5D index (EQ 5D) at 52 weeksBaseline and 52 weeks
Scapula Assisted TestBaseline
Change in Euro Qol 5D index (EQ 5D) at 12 weeksBaseline and 12 weeks
Change in Disability of the Arm, Shoulder and Hand questionnaire at 52 weeksBaseline and 52 weeks

Other

MeasureTime frameDescription
Change in tendon quality measured on ultra-sonography at 12 weeksBaseline and 12 weeks
Baseline demographic and Socioeconomic variables measured at 52 weeksBaseline and 52 weeksAge, sex, duration of symptoms, symptom history, number of patients receiving corticosteroid injections, visits at the patients general practitioner related to their shoulder problem, visits at the secondary healthcare system related to their shoulder problem, sick leave

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026